USANA Health Sciences Inc ( (USNA) ) has released its Q3 earnings. Here is a breakdown of the information USANA Health Sciences Inc presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
USANA Health Sciences Inc., a company specializing in nutritional supplements, functional foods, and personal care products, operates in the direct selling industry with a significant presence in various international markets.
In its third-quarter earnings report for 2025, USANA Health Sciences Inc. reported a 7% increase in net sales year-over-year, reaching $214 million. However, the company faced a net loss of $6.5 million compared to net earnings of $10.6 million in the same quarter of the previous year. The company also introduced an enhanced Brand Partner compensation plan aimed at modernizing its business model.
Key financial metrics highlighted a decline in adjusted EBITDA by 44% to $13.8 million, and a decrease in active customers in the direct selling segment to 388,000. The company’s direct-to-consumer business, Hiya, showed promising growth with a 26% increase in sales year-to-date and a strategic transition to a new logistics partner to enhance operational efficiency.
Looking ahead, USANA has updated its fiscal year 2025 outlook, projecting consolidated net sales of $920 million. The company anticipates continued growth in its Hiya segment and remains focused on aligning costs with current sales levels to improve profitability. Management remains optimistic about the long-term growth potential of its direct selling business and the strategic initiatives undertaken.